These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 27089658)

  • 1. [Protein S-Specific Activity as an Indicator of Thrombophilia].
    Hamasaki N
    Rinsho Byori; 2015 Dec; 63(12):1412-8. PubMed ID: 27089658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C anticoagulant system dysfunction and thrombophilia in Asia.
    Hamasaki N; Kuma H; Tsuda H
    Ann Lab Med; 2013 Jan; 33(1):8-13. PubMed ID: 23301217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of inherited thrombophilia].
    Morishita E
    Rinsho Ketsueki; 2017; 58(7):866-874. PubMed ID: 28781286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Vein Thrombosis Post CABG Precipitated by Malposition of Subclavian Central Catheter in Protein C & S Deficiency Patient.
    Sabzi F; Faraji R
    Ethiop J Health Sci; 2015 Jul; 25(3):283-8. PubMed ID: 26633933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.
    Koenen RR; Gomes L; Tans G; Rosing J; Hackeng TM
    Thromb Haemost; 2004 Jun; 91(6):1105-14. PubMed ID: 15175796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing.
    Marlar RA; Gausman JN
    Methods Mol Biol; 2017; 1646():145-151. PubMed ID: 28804825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombophilia screening in the acute phase of deep venous thrombosis.
    Münster AM; Sidelmann JJ; Gram J
    Scand J Clin Lab Invest; 2009; 69(6):633-5. PubMed ID: 19572231
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired and Heritable Thrombophilia in Indian Patients With Pediatric Deep Venous Thrombosis (DVT).
    Pai N; Ghosh K; Shetty S
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):573-6. PubMed ID: 23406614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III families.
    Castoldi E; Maurissen LF; Tormene D; Spiezia L; Gavasso S; Radu C; Hackeng TM; Rosing J; Simioni P
    Haematologica; 2010 Apr; ():. PubMed ID: 20378562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical diagnosis of thrombosis and blood coagulation tests].
    Watanabe K
    Rinsho Byori; 1998 Mar; 46(3):235-44. PubMed ID: 9564763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulability test strategies in the protein C and protein S pathway.
    Van Cott EM; Soderberg BL; Laposata M
    Clin Lab Med; 2002 Jun; 22(2):391-403. PubMed ID: 12134467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay.
    Sugimura M; Kobayashi T; Kanayama N; Terao T
    Semin Thromb Hemost; 1999; 25(5):497-502. PubMed ID: 10625209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticoagulant protein C pathway.
    Dahlbäck B; Villoutreix BO
    FEBS Lett; 2005 Jun; 579(15):3310-6. PubMed ID: 15943976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of the anticoagulant properties of high-density lipoprotein-brief report.
    Fernandez JA; Deguchi H; Banka CL; Witztum JL; Griffin JH
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):570-2. PubMed ID: 25550205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
    Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
    J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the endothelial protein C receptor gene and thrombophilia.
    Medina P; Navarro S; Estellés A; España F
    Thromb Haemost; 2007 Sep; 98(3):564-9. PubMed ID: 17849044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing issues for protein C, protein S, and antithrombin.
    Marlar RA; Gausman JN
    Int J Lab Hematol; 2014 Jun; 36(3):289-95. PubMed ID: 24750675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.